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Statistical Methods
Because data and their analyses often constitute thesupporting evidence for inferences drawn from stud-ies submitted to the Journal, the Editors remindauthors that all manuscripts with statistical analysesundergo statistical review by the Journal. The review
includes study design, analysis, interpretation, and reporting. The
manuscripts are not published without an acceptable rating by the
statistical editorial staff. Therefore, to minimize revision and de-
lays, authors should request review of such manuscripts by a
statistician prior to submission. This is best done by involving a
statistician as a collaborator from the inception to completion of
the study.
The Editors subscribe to the statistical guidelines contained in
the “Uniform Requirements for Manuscripts Submitted to Bio-
medical Journals” (Ann Intern Med 1997;126;36-47). These are as
follows:
Describe statistical methods with enough detail to enable
a knowledgeable reader with access to the original data to
verity the reported results. When possible, quantify find-
ings and present them with appropriate indicators of mea-
surement error or uncertainty (such as confidence inter-
vals). Avoid relying solely on statistical hypothesis
testing, such as the use of P values, which fails to convey
important quantitative information. Discuss the eligibility
of experimental subjects. Give details about randomiza-
tion. Describe the methods for and success of any blind-
ing observations. Report complications of treatment. Give
numbers of observations. Report losses to observation
(such as dropouts from a clinical trial). References for the
design of the study and statistical methods should be to
standard works when possible (with pages stated) rather
than to papers in which the designs or methods were orig-
inally reported. Specify any general-use computer pro-
grams used.
Put a general description of methods in the Methods sec-
tion. When data are summarized in the Results section,
specify the statistical methods used to analyze them. Re-
strict tables and figures to those needed to explain the
argument of the paper and to assess its support. Use
graphs as an alternative to tables with many entries; do
not duplicate data in graphs and tables. Avoid non-techni-
cal uses of technical terms in statistics, such as “random”
(which implies a randomizing device), “normal,” “signifi-
cant,” “correlations,” and “sample.” Define statistical
terms, abbreviations, and most symbols.
We recognize that there are a number of schools of differing
statistical philosophy, and we take these differences into account.
Nevertheless, over the years, a number of specific items have been
raised repeatedly by statisticians when reviewing manuscripts. The
Editors have compiled a list of these and present them in the form
of guidelines, with the intent of being helpful to authors, not
prescriptive. The guidelines have been formulated as a checklist
and appear twice yearly, in the January and July issues.
Statistical Guidelines for Manuscript Submission
Authors should prepare manuscripts in light of the guidance pro-
vided in “Notes from the Editors” (J Thorac Cardiovasc Surg.
1996;112:209-20). Authors should also consult published check-
lists such as Gardner MJ, Machin D, Campbell MJ, “Use of Check
Lists in Assessing the Statistical Content of Medical Studies”
(BMJ. 1986;292:810-2) and Bailar JC, Mosteller F, “Guidelines
for Statistical Reporting in Articles for Medical Journals” (Ann
Intern Med. 1988;108:226-73). For papers reporting events after
heart valve procedures, consult Edmunds LH Jr, Clark RE, Cohn
LH, Grunkemeier GL, Miller DC, Weisel RD, “Guidelines for
Reporting Morbidity and Mortality After Cardiac Valvular Oper-
ations. Ad Hoc Liaison Committee for Standardizing Definitions
of Prosthetic Heart Valve Morbidity of The American Association
for Thoracic Surgery and The Society of Thoracic Surgeons”
(J Thorac Cardiovasc Surg. 1996;112:708-11). For reports of
randomized clinical studies, consult Begg C, Cho M, Eastwood S,
Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz K, Simel
D, Stroup DF, “Improving the Quality of Reporting of Random-
ized Controlled Trials” (JAMA. 1996;276:637-9). See also Pianta-
dosi S, Gail M, “Statistical Issues Arising in Thoracic Surgery
Clinical Trials.” In: Pearson FG, Deslauriers J, Ginsberg RJ,
Hiebert CA, McKneally MF, Urschel HC Jr, editors. Thoracic
Surgery. New York: Churchill Livingstone; 1995. p. 1652-70, and
Kirklin JW, Barratt-Boyes BG, “The Generation of Knowledge
From Information, Data and Analyses.” In: Cardiac Surgery, New
York: Churchill Livingstone; 1993. p. 249-82.
Checklist
Notation and terminology. Explain meaning of notations such as
SE, SD, CL, or CI in abstract, methods, and tables when they first
appear. Distinguish between a variable, an item that can take on
different values for each subject or observation, such as tempera-
ture and blood pressure, and a parameter, a constant, such as the
mean. Distinguish between prevalence, a proportion of subjects
or observations, and incidence or rate, a quantity expressed per
unit of time. Distinguish between multivariable, referring to
several predictor or explanatory variables or risk factors, and
multivariate, referring to simultaneous analysis of several out-
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come variables. The latter is a relatively recent change in statistical
definitions. An accessible source of statistical terms can be found
in Piantadosi S, Kirklin J, Blackstone E. Statistical Terminology
and Definitions. In: Pearson FG, Deslauriers J, Ginsberg RJ,
Hiebert CA, McKneally MF, Urschel HC Jr, editors. Thoracic
Surgery. New York: Churchill Livingstone; 1995. p. 1649-52.
Distinguish between descriptive statistics and expression of un-
certainty of parameter estimates. When describing the values for
a variable (eg, baseline information), descriptive statistics such as
median and quartiles or the mean and standard deviation are
appropriate. In particular, when the distribution of values is
skewed, nonparametric descriptors such as quartiles are appropri-
ate, not mean and standard deviation. In contrast, the uncertainty of
parameter estimates is expressed commonly in terms of confidence
limits (intervals) or, when these are symmetric, the standard error.
P values. Although it is not possible with all statistical tests, and
although it is contrary to some statistical philosophies, we recom-
mend use of exact P values unless P  .001 or P  .2 as measures
of evidence. Thus, we recommend against use of “P  .05 was
considered significant” or the abbreviation NS, or symbols repre-
senting various levels of statistical significance.
Authors sometimes interpret large P values to mean, “There is
no difference between groups.” This is generally contrary to the
facts because differences are evident. We prefer the use of the
phrase, “The differences could be due to chance (P  .2).”
The term “significant” is ambiguous, because it fails to distin-
guish so-called statistical from clinical significance. We recom-
mend against the use of the term “significant,” suggesting that a
synonym such as “important” be used to signify “clinical signifi-
cance.” Statistical significance often can go unstated when accom-
panied by a P value.
P values alone do not convey the magnitude of the effect or
difference, nor its precision. Therefore, we will recommend the use
of estimates of strength (eg, coefficients, odds ratios, hazard ratios)
and confidence limits (intervals), tolerance intervals, or credibility
intervals to convey this information. Use of these intervals is
particularly important when the conclusion is that no effect or
association was observed (equivalence).
Other specific expressions of uncertainty. In many settings, par-
ticularly when the number of patients or subjects is small, propor-
tions should be accompanied by confidence limits (intervals). We
do not prescribe a specific confidence interval, such as 95%, or
intervals equivalent to1 standard deviation, since the appropriate
confidence limits may vary with the situation. A consistent schema
for expressive variability would include 1 standard deviation for
normally distributed continuous variables, 15 and 85 percentiles
for skewed distributions, and 70% confidence limits for propor-
tions. Increasingly, approximations to parameter estimation and
measures of uncertainty are being supplemented by computer-
intensive resampling (bootstrap) methods.
Presentation of time-related events. In most circumstances, we
recommend that the following information accompany presenta-
tions of time-related events: point estimates, preferably at the time
of each event using a product limit method; asymmetric confidence
limits at periodic intervals; and the number of patients at risk at
periodic intervals.
Nonrandomized comparisons. Unlike experimental comparison
studies that nearly always should be randomized, randomization in
the clinical setting is often neither feasible nor ethical. Incresingly,
multivariable matching methods for adjusting for ascertainable
selection bias are becoming prevalent, well understood, and ac-
cessible (eg, use of propensity scores).
Mutliple group comparisons and repeated measurements. In
comparing three or more groups, statistical methods appropriate
for multiple group comparisons and contrasts should be employed.
If these groups have a natural ordinal relationship one with an-
other, then methods that account for trend should be employed.
When multiple measurements are obtained across time in the same
patient or subject, methods of longitudinal data analyses (a rela-
tively new field of statistics that has supplanted traditional repeated
measures methodology) are recommended.
Multivariable analyses. Many studies lend themselves to methods
that take into account simultaneously multiple variables (risk fac-
tors, predictor variables, independent variables, co-variables). Re-
ports of multivariable analyses must state the model used, all
variables that were examined, how the variables were coded in the
final models, the extent of testing for interactions, the degree to
which conformity to a linear gradient (for continuous or ordinal
variables) was examined and accounted for, the degree to which
the assumption of proportional hazards was tested when using such
models, colinearity of variables, possibility of overfitting, and
methods used for model validation.
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